StockData
Zenas BioPharma, Inc. logo

Zenas BioPharma, Inc. (ZBIO) stock

ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$27.93−0.08 (-0.29%)

Close on Nov 16, 2026Market cap $1.82BP/E –Yield –

Zenas BioPharma operating margin

Operating margin is operating income as a percentage of revenue.

Zenas BioPharma's operating margin for the twelve months ending Dec 31, 2025 was -3830.6%. For fiscal 2025 it was -3830.6%, against -3277.8% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-3830.6%−552.8
FY2024Dec 31, 2024-3277.8%−3203.5
FY2023Dec 31, 2023-74.3%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-1034.1%−1105.3
Q2 FY2026Jun 30, 2026-10765.9%–
Q1 FY2025Mar 31, 2025-373.3%–
Q4 FY2024Dec 31, 2024-1112.5%–
Q3 FY2023Sep 30, 202371.2%–

More Zenas BioPharma figures

See a number that looks wrong?